Baxter (BAX) To Report Q4 Earnings: What's In The Cards?
Zacks Investment Research | Jan 27, 2020 08:58PM ET
Baxter International Inc. (NYSE:BAX) is expected to release fourth-quarter 2019 results on Jan 30, before the opening bell. In the last reported quarter, the company reported preliminary third-quarter revenues but did not release any earnings number.
Q4 Estimates
Currently, the Zacks Consensus Estimate for fourth-quarter revenues is pegged at $2.95 billion, suggesting growth of 3.7% from the year-ago reported figure. The consensus mark for earnings is pegged at 87 cents per share, indicating an improvement of 11.5% from the prior-year quarter.
Factors at Play
New product launches, including PrisMax in the United States, and rising global demand for the company’s continuous renal replacement therapies is likely to have contributed to Baxter’s Acute Therapies business. This, in turn, is likely to have driven the segment’s fourth-quarter performance.
Continued geographic expansion is anticipated to get reflected in the company’s fourth-quarter revenues. Notably, per the company’s preliminary announcement, revenues are anticipated to total $3 billion, up 7% year over year on a reported basis and 9% on an operational basis.
Baxter International Inc. Price and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.